BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25622852)

  • 21. Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion.
    Demir M; Dirim B; Acar Z; Sendul Y; Oba E
    Indian J Ophthalmol; 2014 Mar; 62(3):279-83. PubMed ID: 23571251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema.
    Sonoda S; Sakamoto T; Yamashita T; Otsuka H; Shirasawa M; Kakiuchi N; Uchino E; Terasaki H; Kawano H
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3979-85. PubMed ID: 24906857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
    Synek S; Veselý P
    Coll Antropol; 2011 Sep; 35(3):841-5. PubMed ID: 22053565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
    Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
    Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
    Song JH; Lee JJ; Lee SJ
    Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.
    Radwan AE; Arcinue CA; Yang P; Artornsombudh P; Abu Al-Fadl EM; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1801-6. PubMed ID: 23519884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
    Rahimi M; Shahrzad SS; Banifatemi M
    Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema.
    Yilmaz T; Cordero-Coma M; Gallagher MJ; Teasley LA
    Acta Ophthalmol; 2011 Dec; 89(8):709-17. PubMed ID: 20645926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
    Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF
    Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
    Kwon SI; Kim YW; Bang YW; Lee JY; Park IW
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion.
    Ramezani A; Esfandiari H; Entezari M; Moradian S; Soheilian M; Dehsarvi B; Yaseri M
    Acta Ophthalmol; 2014 Nov; 92(7):e530-9. PubMed ID: 24373344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL; Morrison JL; Constantinou M; Rogers S; Sandhu SS; Wickremasinghe SS; Kawasaki R; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
    Shimura M; Yasuda K; Minezaki T; Noma H
    Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.
    Ramezani A; Esfandiari H; Entezari M; Moradian S; Soheilian M; Dehsarvi B; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1149-60. PubMed ID: 22331147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.